Richard E. Lowenthal - PRESIDENT AND CEO, Director, 10%+ Owner at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: PRESIDENT AND CEO, Director, 10%+ Owner
Issuer Symbol: SPRY on Nasdaq
All Insider Reports: All Insider Reports

Richard E. Lowenthal - trading volume in the past year for ARS Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-50,000	100%	$14.49	-$724,345
Net	-50,000	-100%		-$724,345

Holdings reported by Richard E. Lowenthal for ARS Pharmaceuticals, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	8,859,200	$162,566,320	$18.35	21 Aug 2025	By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Common Stock	1,247,447	$22,890,652	$18.35	21 Aug 2025	By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Common Stock	1,196,494	$17,333,488	$14.49	21 Aug 2025	By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
Stock option (right to buy)	767,600			02 Jan 2025	Direct	Common Stock
Stock Option (right to buy)	261,900			02 Jan 2025	By Spouse	Common Stock

Transactions reported by Richard E. Lowenthal for ARS Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.